Holen Sie sich die Stockscreener-App
3.00
5.66%
-0.18
Handel nachbörslich:
3.03
0.03
+1.00%
Schlusskurs vom Vortag:
$3.18
Offen:
$3.12
24-Stunden-Volumen:
51,441
Relative Volume:
0.26
Marktkapitalisierung:
$25.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-7.98%
1M Leistung:
-25.93%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.95
$3.36
1-Wochen-Bereich:
$2.95
$3.685
52-Wochen-Spanne:
$2.74
$8.50
Firefly Neuroscience Inc Stock (AIFF) Company Profile
Firmenname
Firefly Neuroscience Inc
Sektor
Branche
Telefon
888-237-6412
Adresse
1100 MILITARY ROAD, KENMORE
Vergleichen Sie AIFF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AIFF | 3.00 | 25.83M | 0 | 0 | 0 | 0.00 |
| CRM | 322.25 | 310.95B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 231.30 | 269.17B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,005.34 | 208.67B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 678.81 | 192.68B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 69.33 | 143.75B | 41.96B | 4.40B | 5.96B | -0.22 |
Firefly Neuroscience Inc Aktie (AIFF) Neueste Nachrichten
Firefly Neuroscience Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$0.18 loss in 3Q 2023) - Yahoo Finance
Information Analysis Incorporated : Announces $2,800,000 Equity Financing - Marketscreener.com
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - The Manila Times
Reklaim Ltd (MYID-X) QuotePress Release - The Globe and Mail
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update - GlobeNewswire Inc.
4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event - The Manila Times
Nano Nuclear Energy Inc (NNE-Q) QuotePress Release - The Globe and Mail
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Arbor Realty Trust Schedules Third Quarter 2024 Earnings Conference Call - ForexTV.com
Midnight Sun Mining Corp (MDNGF) QuotePress Release - The Globe and Mail
Gold prices fall but record highs remain in sight - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds and Firefly Neuroscience Renew Collaboration - TipRanks
What's Going On With Bright Minds Biosciences Stock? - Benzinga
Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis - MarketWatch
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds, Firefly Neuroscience to collaborate after BREAKTHROUGH study - TipRanks
Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer - The Manila Times
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data - ForexTV.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Manhattan Associates (MANH) Stock Dips 1.52% Amid Broader Softwa - GuruFocus.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis - Benzinga
Firefly and Bright Minds collaborate on brain health AI - Investing.com India
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views - Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results - MSN
Firefly and Bright Minds collaborate on brain health AI By Investing.com - Investing.com South Africa
Firefly Neuroscience, Bright Minds collaborate to analyze study data on BMB-101 - TipRanks
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology - The Manila Times
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder - The Manila Times
Firefly Neuroscience to Participate in Upcoming October Investor Conferences - EIN News
Arrivo BioVentures Begins Phase 1 Study of SP-624, the First Potential Treatment Specifically for Women with Major Depressive Disorder - Business Wire
Firefly Neuroscience, Zeto Agree To EEG Headset Distribution Deal - MPO-mag
Firefly Neuroscience, Zeto Agree to EEG Headset Distribution Deal - MPO-mag
AIFF stock touches 52-week low at $2.74 amid market challenges - Investing.com Australia
AIFF stock touches 52-week low at $2.74 amid market challenges By Investing.com - Investing.com South Africa
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events - StockTitan
AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - Investing.com
Strategic Announcement Drove Firefly (AIFF) Stock After-Hour - Stocks Telegraph
Firefly partners with pharma giants to enhance drug development - Investing.com
Finanzdaten der Firefly Neuroscience Inc-Aktie (AIFF)
Es liegen keine Finanzdaten für Firefly Neuroscience Inc (AIFF) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.59%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):